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Abstract: Air pollution has become an emerging invisible killer in recent years and is a major cause of
morbidity and mortality globally. More than 90% of the world’s children breathe toxic air every day.
India is among the top ten most highly polluted countries with an average PM10 level of 134 µg/m3
per year. It is reported that 99% of India’s population encounters air pollution levels that exceed the
World Health Organization Air Quality Guideline, advising a PM2.5 permissible level of 10 µg/m3.
Maternal exposure to air pollution has serious health outcomes in offspring because it can affect
embryonic phases of development during the gestation period. A fetus is more prone to effects from
air pollution during embryonic developmental phases due to resulting oxidative stress as antioxidant
mechanisms are lacking at that stage. Any injury during this vulnerable period (embryonic phase)
will have a long-term impact on offspring health, both early and later in life. Epidemiological studies
have revealed that maternal exposure to air pollution increases the risk of development of airway
disease in the offspring due to impaired lung development in utero. In this review, we discuss cellular
mechanisms involved in maternal exposure to air pollution and how it can impact airway disease
development in offspring. A better understanding of these mechanisms in the context of maternal
exposure to air pollution can offer a new avenue to prevent the development of airway disease
in offspring.
Keywords: particulate matter; air pollution; maternal-exposure; airway disease
1. Introduction
In recent years, air pollution has become a leading cause of morbidity, mortality, and economic
loss globally [1,2]. Air pollution poses a direct and major threat to human health by inducing serious
respiratory illnesses such as Chronic Obstructive Pulmonary Disease (COPD) and Asthma, and by also
acting as a trigger of various forms of chronic interstitial lung diseases and lung cancer. The severity
of air pollution is gauged by measuring air particulate matter (PM) [3]. PM consists of fine and
coarse particulate matter; fine PM2.5 has an aerodynamic diameter of ≤2.5 µm, while the coarse PM10
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is ≤10 µm. Both PM types primarily emanate from vehicles, industrial exhausts, and household
sources [4]. It is well established that both PM2.5 and PM10 can cause serious respiratory damage [5].
According to a World Health Organization (WHO) report in 2018, the adverse effects produced by
air pollution are responsible for 8 million premature deaths every year [6]. Air pollution contributed
to at least 23% of deaths from lung cancer, 43% occurring through respiratory disease, 24% from
strokes, and 23% from ischemic-heart-disease-related deaths [7]. However, India surpassed all other
countries, showing the highest number of deaths due to air pollution and accounting for 2.5% of the
25% of air-pollution-related deaths globally [8]. Ninety-one percent of the world’s population inhale
poor-quality air with air pollution levels that exceed the WHO guideline. Rapid industrialization and
modernization further aggravate this situation by increasing airborne PM levels.
Another important factor of concern is the effect of air pollution during pregnancy, especially
on fetal development. Chronic exposure to increased PM levels during pregnancy is associated
with numerous adverse birth complications, such as pre-term delivery [9], low birth weight [10],
birth small for the gestational age [11], congenital heart defects [12], intrauterine growth restriction
(IUGR) [13,14], stillbirth [15], and spontaneous abortion [16]. Further, associated morbidities include
neurodevelopmental impairment leading to attention deficit hyperactivity disorder (ADHD) and
possible autism [17–19], neurological disorders such as impaired neurocognitive ability, nervous
system sequelae [20], infant eczema [21], and increased risk of childhood asthma [22].
Essentially, PM is a mixture of solid and liquid particles consisting of inorganic and organic
matter, dust particles, polyaromatic hydrocarbons (PAH), volatile organic compounds (VOCs),
sulfates, nitrates, ammonia, and minute quantities of metals (TMs), as well as water and unidentified
compounds [23]. The sources of PM can be divided into indoor and outdoor (ambient). Indoor sources
include cigarette smoking, construction work, cooking with a kerosene stove or conventional wood
burning (chulas), burning of incense or mosquito repellent coils, pesticides and cleaning agents
used in homes, and room fresheners (aerosols) [24]. Outdoor (ambient) sources include industrial
exhaust, diesel vehicles, burning of coal, wood, and road dust. Further sources of PM can be elucidated
depending upon the mode of emission, such as those from anthropogenic and natural sources [25].
Anthropogenic PM sources generally would include burning of coal, petroleum products, biomass,
industrial processing, agricultural activities, vehicular exhaust, and friction between tires and road,
while natural sources would include volcanic eruptions, dust storms, and forest fires [26,27]. The adverse
health effects of PM depend not only on the source of PM but also on the chemical composition that is
adsorbed on its surface [27].
India is the ninth highest polluted country with an average PM10 level of 134 µg/m3 per year.
The eight most polluted countries in descending order are as follows: Pakistan, Qatar, Afghanistan,
Bangladesh, Iran, Egypt, Mongolia, and United Arab Emirates [28]. Of the 100 most polluted cities
around the world, 42 are in India, the top 14 of which are listed in Table 1. Worryingly, 99% of India’s
population is exposed to air pollution levels that exceed the WHO Air Quality Guideline (AQG) PM2.5
permissible levels of 10 µg/m3 [29]. Recent evidence demonstrates that on average, PM2.5 levels in
India are found to be in the range of 10–100 µg/m3 [30,31]. This is highly concerning because according
to the estimates by The Global Burden of Disease, PM2.5 exposure in India is one of the leading risk
factors causing the premature death of approximately 1.67 million people [32,33]. In India, higher
concentrations of PM2.5 are observed in northern regions rather than in the south [30,31,34]. This is
because of the landlocked geographical features of the north leading to poor wind circulation, thus
causing air pollutants to remain in the atmosphere for longer periods. In contrast, southern India is
surrounded by coastal regions wherein sea breeze/wind plays a crucial role in pushing the pollutants
away from the region. Moreover, during winters in north India, the creation of a high-pressure zone
obstructs wind generation, impacting the movement of the pollutants [35]. Among metropolitan
cities in India, New Delhi, Kolkata, Mumbai, and Hyderabad show the maximal PM2.5 levels with an
average concentration of 40–81 µg/m3 per year, again exceeding the permissible levels (40 µg/m3).
Air pollutants in India contribute to a decrease in life expectancy by an average of 3.4 years in the
Toxics 2018, 6, 68 3 of 17
general population [36]. According to reports published by the Environmental Performance Index
(EPI), approximately 3.5 billion people, i.e., half of the world’s population, are exposed to air pollutants;
of these people, three-quarters live in northern region of India [37]. There have been several descriptive
studies conducted in India to find the impact of air pollution in neonates and children, as represented in
Table 2 [38–40]; however, these studies did not explore the underlying pathophysiological mechanisms.
This review highlights the key prevailing issue, and as the magnitude of air pollution and its impact
on human health in India was also presented and discussed at the recently held first WHO Conference
on air pollution in Geneva [6], this timely review will provide stimulus to promote research efforts
to investigate maternal-exposure related health effects. As scientific data demonstrate, air pollution
is rapidly increasing globally, partly because of rapid urbanization, uncontrolled industrialization,
and unambiguity surrounding control measures to effectively reduce it in a timely manner. It has
negatively affected various aspects of human health globally (including India) which is corroborated
by some recent evidence where increased burden of chronic respiratory illnesses were seen in 2016 in
comparison to 1990 in India [41]. In fact, air pollution now has become the second most prominent
cause of disease burden in India not only affecting lung but also affecting other major organs i.e., brain,
heart, kidney. Further, India has a very young population with greater number of children. At the
growing age children are very active physically (i.e., have high oxygen intake per unit body weight),
they also have a faster rate of breathing and are very close to the ground where greater suspended-PM
is available in the ambient air. All these factors make them vulnerable to fine-PM entering deeper into
the lungs leading to both impairment in lung growth (children have greater lung surface area/kg of
body mass) while their lungs are still developing [42]. In addition, PM-availability to the systemic
circulation can also affect other organs negatively. The majority of the Indian population still uses
biomass as a fuel to cook their food (typically 1 h of biomass-exposure is ~300 cigarette smoke, though
the actual composition of both varies greatly [43,44], and biomass-exposure which is ambient air inside
the house further negatively impact the health of children either directly or in utero. One of the studies
found greater oxidative stress to biomass-exposure in children at 8–13 years of age and these children
were more susceptible to the development of airway disease later in life [44]. Air pollution in the
context of India has serious consequences later in life, such as reduced lifespan and we believe rather
than focusing on the end spectrum, we must target at early stages where interventions can be most
effective in reducing poor health outcomes later in life.
This review will provide an overview of many health issues as a result of PM-exposure, both
indoors and outdoors, with special emphasis on maternal exposure and its implications for children’s
health in India. In this context, we also present novel cellular mechanisms underpinning the
development of airway disease in children which may become future drug targets. In addition,
we suggest changes in lifestyle, living/working conditions, and environmental policy prevent/reduce
maternal exposure and subsequent development of airway disease in children. We found fewer clinical
studies from India in this area, but collectively the cellular mechanisms of air pollution-induced poor
respiratory health outcomes will largely remain same therefore some of these mechanistic insights are
drawn from studies conducted globally.
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Table 1. List of the top 14 most polluted Indian cities [45].
RANK CITY PM2.5 LEVEL (Annual Mean, µg/m3)
1 Kanpur 173
2 Faridabad 172
3 Varanasi 151
4 Gaya 149
5 Patna 144
6 Delhi 143
7 Lucknow 138
8 Agra 131
9 Muzaffarpur 120
10 Srinagar 113
11 Gurgaon 113
12 Jaipur 105
13 Patiala 101
14 Jodhpur 98
PM: Particulate matter (Diameter of ≤2.5 µm).
Table 2. List of studies on air pollution that have been carried out in an Indian population.
S. No. Author Study Design Sample Size Exposure ParameterStudied
Comments and
Association
1. Padhy et al.,2009 [44] Case-control
Control (105)
Biomass user (115)
Biomass
smoke
Respiratory
symptoms
Oxidative stress
Hematological
changes
Exposure to biomass
smoke significantly
associated with
respiratory diseases,
oxidative stress, and
hematological changes
2. Awasthi etal., 2010 [42] Cohort
23 children
(10–13 years
of age)
Agriculture crop
residue burning
(ACRB)
Pulmonary
function
Decrease in pulmonary
function with an
increase in air pollutant
levels due to ACRB
3. Kumar et al.,2015 [46] Cohort 3104 children
Indoor
suspended
particulate
matter (SPM)
Asthma
Indoor SPM level was
significantly higher in
asthmatic
children’s houses
4. Singh et al.,2015 [47]
Cross-sectional,
multicenter
44,928 (6–7 year
age group);
48,088 (13–14 year
age group)
Traffic pollution,
maternal and
paternal
smoking
Asthma
Traffic pollution and
maternal and paternal
smoking is associated
with increased
prevalence of asthma
5. Murlidhar etal., 2015 [48] Case-report
11-year-old boy,
malnourished
Secondary
exposure to
sandstone
mining
Silico-tuberculosis
Mother started working
in the mines soon after
her marriage and the
family lives close to
the mines
6. Rumchev etal., 2017 [49] Cohort
170 children
between 1 and
15 years
Indoor exposure
to PM2.5
Respiratory
symptoms
No significant
association between
PM-exposure and
respiratory symptoms
even though odds
are high
2. Evidence of Maternal Air Pollution-Induced Health Effects in Offspring
Studies have revealed that a large number of health issues in offspring can be attributed to
exposure to PM, including reduced lung function, increased chances of lower respiratory infections,
cardiovascular diseases, exacerbation of chronic respiratory disease and premature mortality [37,50].
Birth weight is a key parameter to check for fetal growth. For example, it is now evident that maternal
exposure to PM leads to lower birth weight (<2.5 Kg), preterm deliveries, and IUGR, which are likely
factors associated with increased morbidity and mortality in offspring, as well as heightened risk
of other health complications later in life [51]. PM exposure results in the generation of reactive
oxygen species (ROS) and reactive nitrogen species (RNS), both of which cause oxidative stress
that triggers DNA damage, leading to the development of placental DNA adduct formation [52].
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In addition, one of the PM components, i.e., PAH, binds to placental growth factor receptors, resulting
in an inadequate transplacental nutrient exchange. Transplacental nutrient and oxygen transport
are crucial during the gestation period for regulating normal fetal growth and development [53].
Moreover, PM also contains some inorganic metals such as chromium, aluminum, silicon, titanium,
iron, and copper that result in up-regulation of pro-inflammatory mediators, contributing to pulmonary
inflammation [54]. Inadequate placental perfusion may also cause inflammation, resulting in growth
restriction in utero due to interference with the nutrient–oxygen transfer leading to deoxygenation
of both maternal blood and of the fetus [51]. It has been reported that maternal exposure to PM
alters hematological parameters such as blood coagulation capacity, change in viscosity, and levels
of hemoglobin, platelets, and white blood cells, which further correlates with PM toxicity leading
to adverse fetal growth [55]. In addition to the changes in hematological parameters, there is also
endothelial dysfunction, which is attributed to maternal PM exposure during the gestational period [56].
It has been reported that systemic inflammation and oxidative stress caused by PM exposure can
increase plasma dimethylarginine concentration [57]. As dimethylarginine is an endogenous nitric
oxide (NO) synthase inhibitor [58] which decreases NO levels, as a consequence, increased plasma
dimethylarginine leads to endothelial dysfunction which is linked to impaired vascular function and
increased risk of cardiovascular diseases. Studies also suggest that maternal exposure to PM leads to
changes in a hemodynamic parameters such as an increase in blood pressure, and this may be due to
stimulation of the sympathetic nerve and vasoconstriction [59]. While other studies have shown that
maternal PM exposure during gestational period causes pre-eclampsia due to oxidative stress-induced
changes in blood pressure homeostasis [60,61]. Prolong exposure to PM during childhood (age ranges
from 3–9 years) results in reduced lung growth as well as lung function deficits in children [62,63].
Some cohort studies also demonstrate that prolong PM exposure in healthy children had a short
and long-term impact on pulmonary function based on spirometry [64]. However, pollutant derived
oxidative stress in pregnant mothers can block the NO-mediated vasodilatation, leading to increased
blood pressure which adversely affects offspring and leads to pre-term delivery and IUGR [65].
Further, maternal PM exposure also results in inadequate fetal development [66] mainly due to
abnormal blood flow to the fetus. This decrease in blood flow triggers inflammatory signals to release
parturition associated cytokines, which results in membrane rupture, cervical ripening, and myometrial
contraction and ultimately contributes to premature delivery [67], a plausible mechanism for PM
exposure induced complications in offspring.
3. Maternal Air Pollution Exposure and Airway Disease
Although smoking is the greatest risk factor for the development of COPD, other exposure factors
such as air pollution have emerged as significant, with the WHO estimating that 14% of premature
deaths are a result of air-pollution-induced COPD globally [68]. COPD symptoms include wheezing,
breathlessness, chronic cough, and further severe exacerbations, leading to reduced quality of life
with a rapid decline in lung function [69–72] and risk of early mortality [73]. Asthma is one of the
most prevalent pediatric chronic inflammatory respiratory diseases and is characterized by reduced
airflow, airway hyperresponsiveness, and airway remodeling [74]. However, it is known that airflow
obstruction in asthma is reversible while it is irreversible in COPD, mainly due to extensive loss of the
small airways in COPD; this has major implications for mortality in the later stages of the disease [75].
Epidemiological studies have found a strong association between air pollution and the incidence
of asthma in children [76,77]. However, many studies also indicate that these associations begin in
utero [77–80]. There is strong evidence that maternal immunity plays a pivotal role in fetal–infant
immune response development [81]. Maternal allergies may delay the onset of transformation to a
nonallergic immune response to inhaled allergens in children, thereby increasing the chances for the
development of allergic sensitization and/or asthma in the offspring [81]. Generally, lungs begin to
develop during the canalicular phase, i.e., 17th–26th weeks of embryonic development. During this
gestation period, the lungs are more prone to oxidative stress as antioxidant defense mechanisms
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are lacking. Further evidence of oxidative stress was observed in a mouse model on day 16, which
resembles the canalicular stage of human pulmonary development. This model demonstrated a
decrease in the number of peripheral airway branches and in alveoli formation [81].
It has been established that air pollution causes oxidative stress by impairing cellular endogenous
antioxidant production capabilities and thus increasing ROS generation [82]. This increase in ROS leads
to mitochondrial dysfunction and oxidative stress which can further damage the tissue by modifying
the function of vital proteins such as NADH-ubiquinone reductase, succinate-ubiquinone reductase,
cytochrome c oxidase [83]. Increases in ROS is also known to causes endoplasmic reticulum (ER)
stress leading to the upregulation of inflammatory genes as well as impairment of the autophagic
process, thus further aggravating the pathogenesis. Autophagy is a protective catabolic process which
facilitates lysosomal-mediated degradation or clearance of misfolded or unwanted proteins. Oxidative
stress causes ER stress and lipid peroxidation, resulting in mitochondrial dysfunction and pulmonary
and placental inflammation; this negatively affects the nutrient and fetal oxygen transport system,
ultimately leading to impairment in fetal lung development [56,84–87]. Similarly, maternal exposure
to air pollution causes oxidative stress and mitochondrial impairment in the fetus which triggers
pulmonary and placental inflammation and negatively affects nutrient and oxygen transport [87].
Moreover, adsorbed transition metals in air pollution further aggravate ROS generation by the
process of Fenton’s reaction [83]. Fenton’s reaction leads to the subsequent activation of cellular
signaling cascades and the activation of inflammatory cells and release of pro-inflammatory cytokines
leading to pulmonary and placental inflammation [56,88]. Figure 1 summarizes how in uteral air
pollution-induced ROS generation and subsequent cellular oxidative stress can affect a variety of
cellular functions leading to impairment of fetal lung growth and ultimately the development of
airway disease in children.
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Figure 1. Plausible mechanisms for the development of airway disease in offspring. Air pollution
induces ROS generation; this leads to oxidative stress followed by endoplasmic reticulum (ER) stress
and lipid peroxidation, resulting in up-regulation of inflammatory genes. These cause pulmonary
and placental inflammation a d th reby egatively ffect the nutrient and fetal oxygen transport
system. Excessive ROS generation also results in itochondrial damage and induction of autophagy.
Thus, oxidative stress, ER stress, autophagy, and mitochondrial damage cause impaired fetal lung
development, leading to the development of airway disease early or later in life.
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4. In Utero Cellular Mechanisms Involved in the Development of Airway Disease
Maternal exposure to air pollution affects the developing fetus and can be deleterious in terms of
its impacts on the offspring’s lung health and consequential development of airway disease later in life.
The cellular mechanisms/pathways involved are shown in Figure 2, and some of the key pathways
are described below.
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Figure 2. Cellular mechanisms invol ed in maternal exp s r to air pollution. Air polluta ts enter
the lungs while breathing and i creas s ROS generation r i g in oxidative stress. Increase in ROS
causes mitochondrial amage whic can i itiate cell deat t r gh various mechanisms. Oxidative
stress induces ER stress that allows immunoglobulin binding protein (BiP) to bind misfolded ER
proteins and release activating transcription factor-6 (ATF-6), which is then transported to Golgi
apparatus and cleaved to 50 kDa form-ATF6 (p50). p50 in the nucleus drives transcription of many acute
phase response (APR) and inflammatory genes. ER stress also activates inositol-requiring enzyme 1
alpha (IRE1α) kinase which recruits receptor-associated factor 2 (TRAF2) leading to the phosphorylation
of Jun N-terminal kinase (JNK) and enhances activator protein-1 (AP-1)-dependent transcription of
various cytokines and chemokines. O the ER membrane, inositol 1,4,5-trisphosphate receptor (IP3R)
interacts with Beclin-1 which inhibit autophagy. However, inhibition of IP3R initiates detachment
from Beclin-1 leading to autophagy in absence of calcium. Interaction of TRAF2 with apoptosis
signal-regulating kinase 1 (ASK-1) lead to JNK activation which promotes B-cell lymphoma-2 (Bcl-2)
phosphorylation, leading to detachment from Beclin-1. PERK interaction to phosphorylated EIF2α
can lead to autophagy through an interaction of activating transcription factor-4 (ATF-4) dependent
autophagy-related gene-12 (Atg12) protein expression. Alternatively, P8 protein interaction with
ATF-4 stimulates the up-regulation of pseudokinase tribbles homolog-3 (TRB3) which further leads to
activation of autophagy by inhibition of the Akt/mTORC1 complex.
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4.1. ER Stress
The endoplasmic reticulum (ER) is one of the key cellular organelles and plays a pivotal role in
biosynthetic and signaling functions in the cell. The ER is associated with Ca2+ homeostasis as well as
Ca2+-mediated signaling cascades. The ER also provides the platform for the synthesis, folding, and
modification of biomolecules which are to be secreted in the plasma membrane [89,90]. These processes
are assisted by various intrinsic chaperones and Ca2+-binding glucose-regulated proteins 78 (GRP78)
or BiP (immunoglobulin heavy chain binding protein), calreticulin, calnexin, and protein folding
enzymes, such as the thioredoxin-like protein disulfide isomerase (PDI) [91]. Misfolded proteins
are retro-translocated to the cytosol through a process known as ER-associated protein degradation
(ERAD), followed by 26S proteasomal degradation. An imbalance between ER protein folding load and
capacity leads to the aggregation of misfolded proteins in the lumen, a condition that causes ER stress.
The defensive or adaptive response of the ER, called Unfolded Protein Response (UPR) elements,
decreases the overloaded protein synthesis to maintain ER homeostasis. The UPR elements regulate
ER homeostasis in a coordinated fashion by shutting down the translation process of proteins along
with a programmed gene transcriptional process to increase ER folding capacity. If this coordinated
gene transcriptional process fails to provide proper ER homeostasis, then the consequential stress
can induce intrinsic cellular apoptotic pathways [92]. Proteasomes are essentially responsible for
clearing the accumulated misfolded protein aggregates in ER; however, when proteasome systems are
dysfunctional, the UPR actively induces autophagy [92,93]. ER stress also induces the upregulation of
inflammatory genes like NFkB and secretion of cytokines such as IL-23 and type I interferon [94,95].
It has been reported that GRP78 attunes UPR activation and plays a pivotal role in embryogenesis [96].
As evident from animal data, mouse pulmonary growth is initiated at Embryonic Day (E) 9.5 by
the process of cell proliferation and differentiation from anterior foregut endoderm. However, the
lung maturation stage is from E16.5 to postnatal Day 5, and is characterized by a decrease in cell
proliferation and the formation of newly differentiated cell types, including alveolar epithelial type-1
(AT-1) and alveolar epithelial type-2 (AT-2) cells, in a distal part of the lung [97]. AT-2 cells are
surfactant-producing cells which act as precursor cells for AT-1 cell synthesis (which provide the
extensive surface area for gas exchange) during the lung developmental stage [98,99]. During the
saccular stage of embryonic development, enhancement of surfactant protein secretion by AT-2 cells
allows the lung to prepare for postnatal respiration [100]. Surfactant plays a crucial role in the reduction
of surface tension; as a result, the lung can inflate with maximum capacity by increasing the compliance,
thereby decreasing the work for breathing. However, AT-2 cells are regulated by ER homeostasis.
An increase in ER stress results in apoptosis of AT-2 cells, thereby reducing surfactant protein secretion.
Thus, ER stress can lead to respiratory dysfunction in offspring [96]. It has been reported that PERK and
IREs regulate crosstalk between protective and apoptotic UPRs signaling [96]. However, modulation
of PERK upon ER stress regulates cell survival signaling by reduction of the translational process via
phosphorylation of Eukaryotic translation initiation factor 2a (eIF-2a) and encourages apoptosis via
the PERK-eIF-2a–ATF4–CHOP pathway [101]. It has been reported that transforming growth factor
(TGF)-β has a pivotal role in the regulation of apoptosis in lung epithelial cells, aside from its role in
bifurcation and septae formation during pulmonary development [102]. It is also reported that ER
Stress and TGF-β/Smad signaling pathways are tightly interlinked and account for apoptosis of AT-2
cells, leading to a decrease in surfactant secretion which in turn affects alveolar epithelium formation
in the developing lung of offspring [96].
4.2. Autophagy
Autophagy means “self-eating”. It is a fundamental and highly conserved process of lysosomal
degradation and recycling of misfolded proteins or damaged cytoplasmic cellular organelles to
maintain cellular homeostasis [103]. The autophagic process includes engulfment of cell organelles
within the vesicular membrane referred to as autophagosomes followed by lysosomal degradation
with the help of lysosomal degradative enzymes [104]. It plays a crucial role in both pathological and
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physiological conditions such as cell survival, cellular energy production, and metabolism, as well as
the innate and adaptive immune system [105,106]. Several studies have demonstrated a hereditary
association of genes involved in the autophagic processes such as ULK1, SQSTM1, MAP1, LC3B,
Beclin-1, and Atg5 in asthmatics. An elevated number of double-membrane structures known as
“autophagosomes” were also found in fibroblast and epithelial cells in asthmatics in comparison with
a healthy population [107,108]. An elevated number of autophagosomes has been reported in lung
samples derived from COPD patients in comparison with healthy volunteers [109]. Under normal
physiological conditions, autophagy plays a protective role in cell survival and clearance of damaged
proteins, whereas in stress conditions its regulation is impaired, leading to the development of various
diseases. It is now known that an altered cellular autophagic process is seen in stress conditions like
asthma and COPD [103]. However, dysregulation of autophagy causes a breakdown of intracellular
components to generate an energy source for extracellular matrix (ECM) production, and generation of
inflammatory mediators and release of pro-fibrotic signaling molecules, resulting in airway remodeling.
Furthermore, it has also been reported that selective autophagy such as mitophagy (elimination of
damaged or dysfunctional mitochondria) and ciliophagy (elimination of damaged cilia or components
of cilia) also comes into play in airway disease [110,111]. The transmembrane proteins Atg9 and
VMP-1 [112,113] are pivotal for autophagosome formation. The assembly formed by Atg1, Atg13,
and Atg17/FIP200 proteins is essential for the relocation of protein Atg9 to the autophagosome,
leading to double-membrane autophagosome formation, a key indicator for autophagy determination.
However, the mammalian target of rapamycin complex1 (mTORC1) regulates autophagy by repressing
the activity of assembly proteins Atg1–Atg13–Atg17/FIP200; thus, inhibition of mTORC1 induces
the initiation of the autophagic process. Furthermore, rapamycin, which blocks mTORC1, results
in the induction of autophagy. Bafilomycin A1 molecule inhibits fusion with autophagosomes and
inhibits vacuolar-type H+-ATPase, leading to the impairment of lysosomal degradation capability [114].
The kinase Akt, which is upstream of regulators of mTORC1, phosphorylates and inactivates TSC2 and
thereby Akt activation stimulates mTORC1 and inhibits autophagy. Increased autophagy in the context
of airway disease acts as a pro-survival factor required for the normal recycling process of damaged
proteins or organelles, and there is an increase in autophagic markers in sputum and peripheral blood
cells in asthma [115].
Autophagy plays a pivotal role in embryogenesis as the autophagic process is initiated during the
fertilization phase from two-cell to eight-cell division. A defect in Beclin-1 protein leads to embryonic
death (E10–E14) with the impairment of neural tube formation [116]. As evident from clinical data,
during the early gestation period, i.e., 7–11 weeks, interstitial extra-villous trophoblast (EVT) cells
occupy the placental side, and a trophoblastic plug restricts the maternal blood flow, resulting in a
hypoxic condition. Moreover, during 12–16 weeks, endovascular EVT dilates the blood vessels in
spiral arteries, leading to an elevation in intervillous space blood flow [117]. Under normal conditions,
there is an increase in autophagic flux to meet physiologic demand whereas under pathological
conditions, decreased autophagy flux results in impairment of lysosomal-dependent degradation.
However, autophagic inhibition in trophoblasts induces inadequate placental blood supply in the
initial phase of the gestation period, leading to a hypoxic condition in the embryo. Furthermore,
release of anti-angiogenic factors from villi due to hypoxic conditions aggravates dysregulation of
trophoblasts by inhibiting the autophagic process.
Thus, autophagic inhibition causes impairment of homeostasis in trophoblast cells. Controlled
regulation of the autophagic process is necessary for reproduction. However the dysregulation of
functional autophagy impacts offspring health because inadequate placental blood flow affects lung
development in offspring [56,117]. In this way, dysregulation of autophagy leads to impaired lung
development, ultimately leading to the development of airway disease.
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4.3. Mitochondrial Damage
Mitochondria are the leading subcellular organelle from which ROS are generated under
physiological conditions during catalyzation of ATP production, which is linked to the electron
transport chain that occurs in the inner mitochondrial membrane. The mitochondrial respiratory
chain has four complexes in the inner membrane where electrons move in a synchronous manner,
i.e., move from a high to a low redox potential, resulting in the generation of mitochondrial membrane
potential [118–120]. Air pollution which has both organic and inorganic compounds is capable of
generating ROS which interfere in the electron transfer chain system by disrupting the Q cycle that
operates between complexes I and III, resulting in mitochondrial superoxide production [121,122].
Air pollutants also have the ability to disrupt mitochondrial permeability transition pore [123], a crucial
molecule that regulates mitochondrial respiration and regulates cellular apoptosis in a controlled
manner [124,125]. However, disruption of the mitochondrial outer membrane by air pollutants leads
to the release of several pro-apoptotic proteins such as cytochrome c, second mitochondria-derived
activator of caspases (SMAC), and apoptosis-inducing factor (AIF) into the cytosol where they activate
apoptotic signaling pathways, ultimately leading to programmed cell death [125,126]. Besides the
direct effects of air pollutants on mitochondria, the physiology of this organelle can also be altered
indirectly by increasing ROS generation and Ca2+ flux in the cell. Even free intracellular calcium
[Ca2+]i plays an important role in regulating the opening and closing of the mitochondrial permeability
transition pore [127]. ROS such as H2O2 can induce a rise of [Ca2+]i in various cells by either inhibiting
sarco/endoplasmic reticulum Ca2+-ATPase (SERCA) or plasma membrane Ca2+-ATPase (PMCA),
leading to the activation of 1, 3, 5-trisphosphate (IP3) receptors [128,129]. Various constituents in
air pollution can directly target the mitochondrial membrane and cause structural damage [83].
The process in which nonfunctional or damaged mitochondria are cleared via mitochondria-selective
autophagy is known as ‘”mitophagy” and has been reported as one of the key mechanisms in the
development of airway disease [130].
5. Conclusion
Air pollution has become a growing concern in recent years in India and globally, causing an
enormous burden to society as well as loss of life. Air pollutants, particularly PM2.5, penetrate
deep into the lungs and cause pathological changes which lead to impaired pulmonary function.
Epidemiological studies demonstrate that exposure to PM induces oxidative stress that leads to
serious health effects. Similar mechanisms are involved in maternal air-pollution-exposure-induced
health effects on offspring that are a result of increased oxidative stress resulting in damage to
proteins and biomolecules and causing placental inflammation, induction of ER stress–autophagy, and
mitochondrial dysfunction. Therapeutic strategies targeting air-pollution-induced oxidative stress and
related signaling should be considered to enhance endogenous antioxidant defense mechanisms in
the cell. On the other hand, use of novel autophagy modulators that can also block ER stress could
be of great value for future research into preventing the development of pollutant-induced airway
disease. Collectively, air-pollution-induced adverse health outcomes can be prevented by adopting
a comprehensive global approach that works locally to eliminate or reduce the burden of PM both
indoors and outdoors.
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